Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
共济失调毛细血管扩张症和 Rad3 相关抑制剂 berzosertib 与伊立替康联合治疗晚期实体瘤患者的 1 期临床试验 (ETCTN 9938)
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.70157
Villaruz, Liza C; Jin, Jingxiao; Wang, Hong; Lee, James J; Luke, Jason J; Rhee, John C; Waqar, Saiama N; Shapiro, Geoffrey I; Cleary, James; Davar, Diwakar; Burns, Timothy F; Verma, Rashmi; Amin, Manik; Appleman, Leonard; Ciombor, Kristen K; Davis, Elizabeth J; Riess, Jonathan W; Dees, E Claire; Kim, Edward J; Cardin, Dana; Guo, Jianxia; Christner, Susan M; Deppas, Joshua; Parise, Angelina M; Schmitz, John C; Guerrouahen, Bella S; Suchko, Michael; Contreras, Alejandro; Li, Li; Ferry-Galow, Katherine V; Chang, Ting-Chia; Jiwani, Shahanawaz; Bakkenist, Christopher J; Chu, Edward; Gore, Steven D; Beumer, Jan H